Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for May 2007
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Genzyme buys cancer specialists Bioenvision
$345m acquisition could make Genzyme a key player in oncology..(more)

 Clew to promote Novartis' Aclasta
Account is latest addition to Clew's growing list of clients..(more)

 Product roundup from Datamonitor
Latest news in ADHD, leukaemia, asthma, cancer and avian flu..(more)

 Report raises safety concerns over Avandia
But GSK says study methodology and evidence deeply flawed..(more)

 PCTs 'overspending' on prescribing
NAO says there is considerable scope for large NHS savings..(more)

 Industry outlines concerns with NICE to Parliament
Health Select Committee to hold second inquiry into workings of the institute..(more)

 Pfizer loses heads of research and finance
LaMattina and Levin go as company continues its restructuring..(more)

 Latest news from Datamonitor
Product roundup in cancer, cardiovascular, obesity and HIV..(more)

 Charity outlines vision for tackling cancer
Cancer UK draws up ambitious list of goals for 2020..(more)

 Edelman scoops European Viagra account
Pfizer hopes new campaign will revive stagnating sales..(more)

 NICE blocks Erbitux for head and neck cancer
Watchdog says Merck didn't prove effectiveness..(more)

 Clinical news from Datamonitor
New trials in Parkinson's and cancer..(more)

 Pharma news from Datamonitor
Heart drug and NSAID collaborations signed..(more)

 Roche selects Ketchum for pandemic work
Agency to promote Tamiflu..(more)

 'Research must be nurtured,' says industry
Flourishing potential needs tending..(more)

 GP prescribing costs contained in '06
New data shows generic simvastatin undermined the UK's biggest seller Lipitor..(more)

 Gates Foundation could rival pharma, analysts warn
IMS Health identifies the non-profit organisation as key to industry's future..(more)

 Date for NICE court showdown announced
Eisai and Pfizer's legal challenge to be heard on 25 June..(more)

 The End of the Junket?
18 months on, the new ABPI Code has changed pharma-doctor relationships..(more)

 AstraZeneca's latest purchase fails to impress investors
'Uninspiring and over-priced' acquisition sees AZ share prices drop..(more)

 Novartis buys rights to smoking vaccine
Company gambles on phase II compound becoming blockbuster..(more)

 NHS managers praise Blair's record
Blair to step down on 27 June..(more)

 NICE attacks 'flawed and inaccurate' cancer report
Roche-sponsored report highlights UK's cancer drug access problems..(more)

 Leapfrog leads Adventis' online drive
Agency's investment aim is to use internet to its full potential..(more)

 Product news roundup from Datamonitor
Latest results in cancer, stem cell therapy, migraine and blindness..(more)

 Take NHS away from politicians, say doctors
BMA proposes appointing an independent board of governors..(more)

 Scottish Sprycel approval turns spotlight on NICE
Fears that lack of NICE appraisal could deny patient access in England and Wales..(more)

 Generic attacks dent Sanofi-Aventis
But overall sales growth reassures investors..(more)

 Herceptin approved for new breast cancer combination
Study gives further boost to drug's growing reputation..(more)

 NHS must prepare for health impact of global warming, say experts
Report warns of increase in heat-related illnesses and skin cancer..(more)

 EMEA gives extension to Celebrex's European arthritis licence
Pfizer welcomes chance for drug to bounce back after sales slump..(more)

 Animal rights extremists arrested in nationwide raids
Industry optimistic that end in sight for activists' terror campaign..(more)

 Free healthcare a 'mirage' in UK
Doctors' group calls for reform..(more)

 UK science at a 'tipping point'
Optimism that UK set to become a true world leader in medical science..(more)

 Product update from Datamonitor
Cholesterol and epilepsy drug news..(more)

 Pharma news from Datamonitor
Leukaemia, cystic fibrosis and HRT updates..(more)

 Industry lobbies ministers ahead of OFT decision
Government suggests compromise on OFT report..(more)

 News update from Datamonitor
Latest company and product developments..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.